At Ori Biotech, we’re addressing one of the greatest challenges in healthcare today: making cell and gene therapies accessible to all who need them. Scientific breakthroughs in these therapies are transforming the treatment of cancer and rare genetic diseases, yet more than 95% of eligible patients still lack access. The reason? These therapies are complex, expensive, and difficult to manufacture at scale. That’s where Ori comes in.
Our team of life sciences veterans and CGT experts is working alongside industry partners to build a better way forward – starting with IRO®, a new standard in CGT manufacturing. Designed to automate better biology and accelerate therapy development, IRO® is the first step on our journey to help make life-saving treatments more affordable, scalable, and widely available.
